Elevated lipoprotein(a) levels: A crucial determinant of cardiovascular disease risk and target for emerging therapies.
Afzal Z, Cao H, Chaudhary M, Chigurupati HD, Neppala S, Alruwaili W, Awad M, Sandesara D, Siddique M, Farman A, Zafrullah F, Gonuguntla K, Sattar Y.
Afzal Z, et al.
Curr Probl Cardiol. 2024 Aug;49(8):102586. doi: 10.1016/j.cpcardiol.2024.102586. Epub 2024 Apr 21.
Curr Probl Cardiol. 2024.
PMID: 38653440
Review.